FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801707625> ?p ?o ?g. }

• W2801707625 endingPage "e0195127" @default.
• W2801707625 startingPage "e0195127" @default.
• W2801707625 abstract "Introduction WHO recommends antiretroviral treatment (ART) for all HIV-positive individuals. This study evaluated the association between baseline CD4 count and attrition in a cohort of HIV positive adults initiating ART at three department of health (DOH) clinics routinely providing ART at baseline CD4 counts >500cells/μL for the HPTN 071 (PopART) trial. Methods All clients attending the DOH clinics were managed according to standard care guidelines with the exception that those starting ART outside of pertinent local guidelines signed research informed consent. DOH data on all HIV-positive adult clients recorded as having initiated ART between January 2014 and November 2015 at the three study clinics was analysed. Attrition, included clients lost to follow up or died, and was defined as ‘being three or more months late for an antiretroviral pharmacy pick-up appointment’. All clients were followed until attrition, transfer out or end May 2016. Results A total of 2423 clients with a median baseline CD4 count of 328 cells/μL (IQR 195–468) were included of whom 631 (26.0%) experienced attrition and 140 (5.8%) were TFO. Attrition was highest during the first six months of ART (IR 38.3/100 PY; 95% CI 34.8–42.1). Higher attrition was found amongst those with baseline CD4 counts > 500 cells/μL compared to those with baseline CD4 counts of 0–500 cells/μL (aHR 1.26, 95%CI 1.05 to 1.52) This finding was confirmed on subset analyses when restricted to individuals non-pregnant at baseline and when restricted to individuals with follow up of > 12months. Conclusions Attrition in this study was high, particularly during the first six months of treatment. Attrition was highest amongst clients starting ART at baseline CD4 counts > 500 cells/μL. Strategies to improve retention amongst ART clients, particularly those starting ART at baseline CD4 counts >500cells/μL, need strengthening. Improved monitoring of clients moving in and out of ART care and between clinics will assist in better understanding attrition and ART coverage in high burden countries." @default.
• W2801707625 created "2018-05-17" @default.
• W2801707625 creator A5012480739 @default.
• W2801707625 creator A5015106185 @default.
• W2801707625 creator A5016061965 @default.
• W2801707625 creator A5029841050 @default.
• W2801707625 creator A5030900698 @default.
• W2801707625 creator A5043019249 @default.
• W2801707625 creator A5043774258 @default.
• W2801707625 creator A5060548814 @default.
• W2801707625 creator A5061318732 @default.
• W2801707625 creator A5067056877 @default.
• W2801707625 creator A5067307694 @default.
• W2801707625 creator A5070944060 @default.
• W2801707625 creator A5079907326 @default.
• W2801707625 creator A5086305494 @default.
• W2801707625 creator A5091777537 @default.
• W2801707625 date "2018-04-19" @default.
• W2801707625 modified "2023-09-25" @default.
• W2801707625 title "Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa" @default.
• W2801707625 cites W1613992416 @default.
• W2801707625 cites W1970024313 @default.
• W2801707625 cites W1970212454 @default.
• W2801707625 cites W1988571126 @default.
• W2801707625 cites W2000874940 @default.
• W2801707625 cites W2055868383 @default.
• W2801707625 cites W2068974996 @default.
• W2801707625 cites W2083484297 @default.
• W2801707625 cites W2084586254 @default.
• W2801707625 cites W2104098309 @default.
• W2801707625 cites W2116350902 @default.
• W2801707625 cites W2122050550 @default.
• W2801707625 cites W2125370438 @default.
• W2801707625 cites W2137413238 @default.
• W2801707625 cites W2145438228 @default.
• W2801707625 cites W2148684707 @default.
• W2801707625 cites W2187955543 @default.
• W2801707625 cites W2238552371 @default.
• W2801707625 cites W2283364506 @default.
• W2801707625 cites W2318673808 @default.
• W2801707625 cites W2324733570 @default.
• W2801707625 cites W2403671454 @default.
• W2801707625 cites W2416378512 @default.
• W2801707625 cites W2435673479 @default.
• W2801707625 cites W2491011421 @default.
• W2801707625 cites W2509432012 @default.
• W2801707625 cites W2519514558 @default.
• W2801707625 doi "https://doi.org/10.1371/journal.pone.0195127" @default.
• W2801707625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5909512" @default.
• W2801707625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29672542" @default.
• W2801707625 hasPublicationYear "2018" @default.
• W2801707625 type Work @default.
• W2801707625 sameAs 2801707625 @default.
• W2801707625 citedByCount "14" @default.
• W2801707625 countsByYear W28017076252018 @default.
• W2801707625 countsByYear W28017076252019 @default.
• W2801707625 countsByYear W28017076252020 @default.
• W2801707625 countsByYear W28017076252021 @default.
• W2801707625 countsByYear W28017076252022 @default.
• W2801707625 countsByYear W28017076252023 @default.
• W2801707625 crossrefType "journal-article" @default.
• W2801707625 hasAuthorship W2801707625A5012480739 @default.
• W2801707625 hasAuthorship W2801707625A5015106185 @default.
• W2801707625 hasAuthorship W2801707625A5016061965 @default.
• W2801707625 hasAuthorship W2801707625A5029841050 @default.
• W2801707625 hasAuthorship W2801707625A5030900698 @default.
• W2801707625 hasAuthorship W2801707625A5043019249 @default.
• W2801707625 hasAuthorship W2801707625A5043774258 @default.
• W2801707625 hasAuthorship W2801707625A5060548814 @default.
• W2801707625 hasAuthorship W2801707625A5061318732 @default.
• W2801707625 hasAuthorship W2801707625A5067056877 @default.
• W2801707625 hasAuthorship W2801707625A5067307694 @default.
• W2801707625 hasAuthorship W2801707625A5070944060 @default.
• W2801707625 hasAuthorship W2801707625A5079907326 @default.
• W2801707625 hasAuthorship W2801707625A5086305494 @default.
• W2801707625 hasAuthorship W2801707625A5091777537 @default.
• W2801707625 hasBestOaLocation W28017076251 @default.
• W2801707625 hasConcept C126322002 @default.
• W2801707625 hasConcept C142462285 @default.
• W2801707625 hasConcept C199343813 @default.
• W2801707625 hasConcept C201903717 @default.
• W2801707625 hasConcept C2780553607 @default.
• W2801707625 hasConcept C2993143319 @default.
• W2801707625 hasConcept C3013748606 @default.
• W2801707625 hasConcept C3019165603 @default.
• W2801707625 hasConcept C512399662 @default.
• W2801707625 hasConcept C71924100 @default.
• W2801707625 hasConcept C72563966 @default.
• W2801707625 hasConceptScore W2801707625C126322002 @default.
• W2801707625 hasConceptScore W2801707625C142462285 @default.
• W2801707625 hasConceptScore W2801707625C199343813 @default.
• W2801707625 hasConceptScore W2801707625C201903717 @default.
• W2801707625 hasConceptScore W2801707625C2780553607 @default.
• W2801707625 hasConceptScore W2801707625C2993143319 @default.
• W2801707625 hasConceptScore W2801707625C3013748606 @default.
• W2801707625 hasConceptScore W2801707625C3019165603 @default.
• W2801707625 hasConceptScore W2801707625C512399662 @default.
• W2801707625 hasConceptScore W2801707625C71924100 @default.

• next